[1]Aghazadeh A,Rutger Persson G,Renvert S.A single-centre randomized controlled clinical trial on the adjunct treatment of intra-bony defects with autogenousbone or a xenograft: results after 12 months.J Clin Periodontol.2012;39(7):666-673.
[2]Ng VY.Risk of disease transmission with bone allograft.Orthopedics.2012;35(8): 679-681
[3]Larsson S,Hannink G.Injectable bone-graft substitutes: current products, their characteristics and indications, and new developments.Injury. 2011;42 Suppl 2: 30-34.
[4]Shepherd JH,Best SM.Calcium phosphates scaffolds for bone repair.JOM.2011; 63(4):83-92.
[5]Cai L,Guinn AS,Wang SF.Exposed hydroxyapatite particles on the surface of photo-crosslinked nanocomposites for promoting MC3T3 cell proliferation and differentiation.Acta Biomater. 2011; 7:2185-2199.
[6]Carrodeguas RG,De Aza S.alpha-Tricalcium phosphate: synthesis, properties and biomedical applications.Acta Biomater. 2011;7(10):3536-3546.
[7]Perez RA,Kim TH,Kim M,et al.Calcium phosphate cements loaded with basic fibroblast growth factor: delivery and in vitro cell response.J Biomed Mater Res A.2013; 101(4):923-931.
[8]Liu S,Jin F,Lin K,et al.The effect of calcium silicate on in vitro physiochemical properties and in vivo osteogenesis,degradability and bioactivity of porous beta-tricalcium phosphate bioceramics.Biomed Mater 2013;8(2):025008.
[9]Ambrosio L,Guarino V,Sanginario V,et al.Injectable calcium-phosphate-based composites for skeletal bone treatments.Biomed Mater.2012;7(2):024113.
[10]Lee JB,Park SJ,Kim HH,et al.Physical properties and biological/odontogenic effects of an experimentally developed fast-setting α-tricalcium phosphate-based pulp capping material.BMC Oral Health.2014;14:87-98.
[11]Hurle K,Neubauer J,Bohner M,et al.Effect of amorphous phases during the hydraulic conversion of α-TCP into calcium-deficient hydroxyapatite.Acta Biomater.2014; 10(9):3931-3941.
[12]Ambrosio L,Guarino V,Sanginario V,et al.Injectable calcium-phosphate-based composites for skeletal bone treatments.Biomed Mater.2012;7(2):024113.
[13]Lange T,Schilling AF,Peters F,et al.Size dependent induction of proinflammatory cytokines and cytotoxicity of particulate beta-tricalcium phosphate in vitro. Biomaterials.2011;32(17):4067-4075.
[14]Vamze J,Pilmane M,Skagers A.Biocompatibility of pure and mixed hydroxyapatite and α-tricalcium phosphate implanted in rabbit bone.J Mater Sci Mater Med.2015;26(2):73.
[15]Moreau JL,Weir MD,Giuseppetti AA,et al.Long-term mechanical durability of dental nanocomposites containing amorphous calcium phosphate nanoparticles. J Biomed Mater Res Part B: Appl Biomater.2012;100B:1264-1273.
[16]Velasquez P,Luklinska ZB,Meseguer-Olmo L,et al.Alpha tcp ceramic doped with dicalcium silicate for bone regeneration applications prepared by powder metallurgy method: in vitro and in vivo studies.J Biomed Mater Res A.2013;101(7):1943-1954.
[17]Bohner M,Tiainen H,Michel P,et al.Design of an inorganic dual-paste apatite cement using cation exchange.J Mater Sci Mater Med.2015;26(2):63.
[18]Tanaka M,Takemoto M,Fujibayashi S,et al. Development of a novel calcium phosphate cement composed mainly of calcium sodium phosphate with high osteoconductivity. J Mater Sci Mater Med. 2014; 25(6):1505-1517.
[19]Thurmer MB,Diehl CE,Brum FJ,et al.Development of dual-setting calcium phosphate cement using absorbable polymer.Artif Organs. 2013;37(11):992-997.
[20]Rosskopfova O,Galambos M,Ometakova J,et al.Study of sorption processes of copper on synthetic hydroxyapatite. J Radioanal Nucl Chem. 2012;293(2):641-647.
[21]Morejon-Alonso L,Ferreira OJ,Carrodeguas RG,et al. Bioactive composite bone cement based on alpha-tricalcium phosphate/tricalcium silicate.J Biomed Mater Res B Appl Biomater. 2012;100(1): 94-102.
[22]Correa D,Almirall A,Carrodeguas RG,et al.α-Tricalcium phosphate cements modified with β-dicalcium silicate and tricalcium aluminate: physicochemical characterization, in vitro bioactivity and cytotoxicity.J Biomed Mater Res B Appl Biomater. 2015;103(1): 72-83.
[23]de Aza PN,Luklinska ZB,Mate-Sanchez de Val JE,et al.Biodegradation process of alpha-tricalcium phosphate and alpha-tricalcium phosphate solid solution bioceramics in vivo: a comparative study.Microsc Microanal.2013;19(5):1350-1357.
[24]Saidak Z,Marie PJ.Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis. Pharmacol Ther.201;136(2):216-226.
[25]Pina S,Torres PM,Goetz-Neunhoeffer F,et al.Newly developed sr-substituted alpha-tcp bone cements.Acta Biomaterialia.2010;6(3):928-935.
[26]Booncharoen W,Jaroenworaluck A,Stevens R.A synthesis route to nanoparticle dicalcium silicate for biomaterials research.J Biomed Mater Res Part B: Appl Biomater.2011;99(2):230-238.
[27]Correa D,Almirall A,Carrodeguas RG,et al.Alpha-Tricalcium phosphate cements modified with beta-dicalcium silicate and tricalcium aluminate: physicochemical characterization, in vitro bioactivity and cytotoxicity.J Biomed Mater Res B Appl Biomater. 2015;103(1):72-83.
[28]Hasan MS,Carpenter N,Wei TL,et al.Effects of adding resorbable phosphate glass fibres and PLA to calcium phosphate bone cements.J Appl Biomater Funct Mater. 2014;12(3):203-209.
[29]Gustavsson J,Ginebra MP,Engel E,et al.Ion reactivity of calcium-deficient hydroxyapatite in standard cell culture media.Acta Biomater.2011;7:4242-4252.
[30]Kim BS,Kim JS,Sung HM,et al.Cellular attachment and osteoblast differentiation of mesenchymal stem cells on natural cuttlefish bone.J Biomed Mater Res Part A. 2012;100A:1673-1679.
[31]Mate-Sanchez de Val JE,Calvo-Guirado JL,Delgado-Ruiz RA,et al.New block graft of alpha-TCP with silicon in critical size defects in rabbits: Chemical characterization, histological, histomorphometric and micro-CT study. Ceram Int. 2012;38:1563-1570.
[32]Canal C,Ginebra MP.Fibre-reinforced calcium phosphate cements: a review.J Mech Behav Biomed Mater.2011;4(8):1658-1671.
[33]Zuo Y,Yang F,Wolke JG,et al.Incorporation of biodegradable electrospun fibers into calcium phosphate cement for bone regeneration.Acta Biomater. 2010;6(4):1238-1247.
[34]Tosetti F,Noonan DM,Albini A.Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals.Int J Cancer. 2009;125(9): 1997-2003.
[35]Lee SH,Kim BJ,Choi HJ,et al. (-)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression ofbone resorption.Calcif Tissue Int. 2012;90(5):404-410.
[36]Weisburger JH.Tea and health: the underlying mechanisms.Proc Soc Exp Biol Med. 1999;220(4): 271-275.
[37]Romas E,Gillespie MT,Martin TJ.Involvement of receptor activator of NF-jB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone.2002;30(2):340-346.
[38]Byun MR,Sung MK,Kim AR,et al.(-)-Epicatechin gallate(ECG) stimulates osteoblast differentiation via Runt-related transcription factor2(RUNX2) and transcriptional coactivator with PDZ-binding motif (TAZ)-mediated transcriptional activation. J Biol Chem. 2014;289(14):9926-9935.
[39]Rodriguez R,Kondo H,Nyan M,et al.Implantation of green tea catechin alpha-tricalcium phosphate combination enhances bone repair in rat skull defects.J Biomed Mater Res B Appl Biomater. 2011; 98(2):263-271.
[40]Jin P,Wu H,Xu G,et al.Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study.Cell Tissue Res.2014;356(2):381-390.
[41]Han DW,Lee MH,Kim B,et al.Preventive effects of epigallocatechin-3-O-gallate against replicative senescence associated with p53 acetylationin human dermal fibroblasts.Oxid Med Cell Longev. 2012;2012: 850684.
[42]Yagi H,Tan J,Tuan RS.Polyphenols suppress hydrogen peroxide-induced oxidative stress in human bone-marrow derived mesenchymal stem cells. J Cell Biochem.2013; 114(5):1163-1173. |